The IQVIA Podcast

In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks.Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics

Join IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.

In this episode you will: Discover how AI can predict the success of clinical trials in terms of efficacy, regulatory approval, operational feasibility, reimbursement attainment and product uptake. Learn why AI can give us deeper insights by analyzing unstructured data for better-informed clinical development decisions. See how an agentic AI approach can speed up what would take months and weeks manually, to days and hours, while looking at even more information for the analysis.   Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions

Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!

IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.

Elyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct-to-consumer advertising (prohibited in other major markets).

IQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and the need for more initiatives in the region to help fight against lung cancer.

In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.

In episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.

This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey’s Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew’s success story and how OneKey has streamlined their operations.Featured speakers:Charles Wallace, OneKey Associate Director Product Offering, IQVIABob Forcier, Director, Smith and Nephew